Inceptionr LLC Has $1.12 Million Position in Tenet Healthcare Corporation $THC

Inceptionr LLC lessened its position in Tenet Healthcare Corporation (NYSE:THC) by 6.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,342 shares of the company’s stock after selling 406 shares during the quarter. Inceptionr LLC’s holdings in Tenet Healthcare were worth $1,116,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the business. Price T Rowe Associates Inc. MD raised its holdings in shares of Tenet Healthcare by 6.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 7,596,544 shares of the company’s stock valued at $1,021,736,000 after purchasing an additional 463,552 shares during the last quarter. Boston Partners grew its position in Tenet Healthcare by 95.0% in the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares in the last quarter. Ameriprise Financial Inc. lifted its position in Tenet Healthcare by 348.4% during the 1st quarter. Ameriprise Financial Inc. now owns 1,962,314 shares of the company’s stock worth $263,905,000 after buying an additional 1,524,642 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Tenet Healthcare by 12.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,675,199 shares of the company’s stock worth $225,297,000 after buying an additional 181,667 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Tenet Healthcare in the first quarter valued at about $218,549,000. 95.44% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, insider R. Scott Ramsey sold 13,322 shares of the business’s stock in a transaction on Thursday, November 6th. The shares were sold at an average price of $205.11, for a total value of $2,732,475.42. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Richard W. Fisher sold 2,500 shares of the stock in a transaction dated Wednesday, October 29th. The stock was sold at an average price of $208.43, for a total value of $521,075.00. Following the sale, the director owned 8,792 shares of the company’s stock, valued at approximately $1,832,516.56. The trade was a 22.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 122,084 shares of company stock valued at $23,843,196. Insiders own 0.81% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on THC shares. Morgan Stanley set a $232.00 price target on Tenet Healthcare and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Mizuho raised their target price on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, October 17th. Royal Bank Of Canada upped their price target on shares of Tenet Healthcare from $230.00 to $252.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Weiss Ratings reissued a “buy (b-)” rating on shares of Tenet Healthcare in a research report on Monday. Finally, Bank of America raised their target price on shares of Tenet Healthcare from $205.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $229.69.

Tenet Healthcare Stock Performance

THC opened at $217.52 on Thursday. The business’s fifty day moving average is $200.69 and its 200-day moving average is $181.56. The firm has a market cap of $19.12 billion, a P/E ratio of 14.91, a price-to-earnings-growth ratio of 0.89 and a beta of 1.53. The company has a debt-to-equity ratio of 2.27, a quick ratio of 1.63 and a current ratio of 1.71. Tenet Healthcare Corporation has a 52-week low of $109.82 and a 52-week high of $221.00.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, topping analysts’ consensus estimates of $3.33 by $0.37. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter in the prior year, the firm posted $2.93 EPS. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.